Published in J Cardiovasc Pharmacol on May 16, 1985
Mitochondrial ion channels. Annu Rev Physiol (2007) 1.70
Oxygen-derived free radicals and myocardial reperfusion injury: an overview. Cardiovasc Drugs Ther (1991) 1.23
Is Kir6.1 a subunit of mitoK(ATP)? Biochem Biophys Res Commun (2007) 1.19
Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest (1987) 0.98
Targeting calcium transport in ischaemic heart disease. Cardiovasc Res (2009) 0.91
Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol Heart Circ Physiol (2003) 0.82
Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility. Cardiovasc Drugs Ther (1995) 0.81
Electrophysiologic effects of potassium channel openers. Cardiovasc Drugs Ther (1995) 0.79
Effects of verapamil on myocardial stunning in xanthine-oxidase deficient hearts: pre-treatment vs. post-ischemic treatment. Basic Res Cardiol (1994) 0.78
Effects of nicorandil on regional perfusion and left ventricular function. Cardiovasc Drugs Ther (1995) 0.76
Beneficial actions of acidotic initial reperfusate in stunned myocardium of rat hearts. Basic Res Cardiol (1992) 0.75
Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech (1999) 1.82
Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology (1997) 1.75
Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J Mol Cell Cardiol (2001) 1.70
Opioids and cardioprotection. Pharmacol Ther (2001) 1.53
BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol (2001) 1.51
Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res (1992) 1.40
Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol (2000) 1.29
Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol (1986) 1.27
Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res (1996) 1.24
Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol (1993) 1.24
Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol (2001) 1.22
Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res (2001) 1.20
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res (1999) 1.20
Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol (1997) 1.18
Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience (2004) 1.17
Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection? Am J Physiol Heart Circ Physiol (2000) 1.15
Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation (1994) 1.14
Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem (2001) 1.13
Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol (1988) 1.13
Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther (2000) 1.11
Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences. Am J Physiol Heart Circ Physiol (2001) 1.09
Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther (2001) 1.09
Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist. J Pharmacol Exp Ther (1981) 1.09
Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol (1995) 1.08
Blocking Na(+)/H(+) exchange reduces [Na(+)](i) and [Ca(2+)](i) load after ischemia and improves function in intact hearts. Am J Physiol Heart Circ Physiol (2001) 1.07
Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat Rec (2001) 1.06
Long-term evaluation of initial filtration surgery. Ophthalmology (1986) 1.05
A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels. Circulation (1994) 1.00
TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol (1998) 1.00
Effects of nicorandil and nifedipine on protection of ischemic myocardium. J Cardiovasc Pharmacol (1984) 1.00
Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology (1996) 1.00
Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog. Cardiovasc Res (1993) 0.99
ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol (2001) 0.99
Preconditioning in immature rabbit hearts: role of KATP channels. Circulation (1999) 0.99
Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation (1998) 0.99
Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Circulation (1992) 0.99
Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol (1998) 0.98
The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol (1997) 0.98
Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. Am J Physiol Heart Circ Physiol (2001) 0.98
The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther (1991) 0.98
PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res (1996) 0.97
The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int (2009) 0.97
Beta adrenergic blockade on intramyocardial distribution of coronary blood flow. J Pharmacol Exp Ther (1973) 0.96
Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res (1999) 0.96
Coronary steal in four models of single or multiple vessel obstruction in dogs. Am J Cardiol (1981) 0.95
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation (1995) 0.95
Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia. J Pharmacol Exp Ther (1981) 0.94
Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract (2001) 0.94
Simultaneous determination of adenosine, inosine, hypoxanthine, xanthine, and uric acid in microdialysis samples using microbore column high-performance liquid chromatography with a diode array detector. Anal Biochem (1996) 0.94
Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res Cardiol (2001) 0.94
Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation (2000) 0.94
A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary artery occlusion. J Pharmacol Exp Ther (1998) 0.94
Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res (1993) 0.93
Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium. Circulation (1993) 0.92
Sarcolemmal and mitochondrial adenosine triphosphate- dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology (2000) 0.92
Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J Cardiovasc Pharmacol (1992) 0.91
Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res Cardiol (2005) 0.91
Alteration in oxyhemoglobin equilibrium (P-50) and myocardial oxygen consumption (MVO2) by nitroglycerin (GTN). J Pharmacol Exp Ther (1975) 0.91
Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart. Circ Res (1988) 0.91
Effects of pentylenetetrazol on ion transport in the isolated toad bladder. J Pharmacol Exp Ther (1972) 0.90
Effect of propranolol on regional myocardial blood flow and oxygen consumption. J Pharmacol Exp Ther (1976) 0.90
Sarcolemmal and mitochondrial K(ATP) channels and myocardial ischemic preconditioning. J Cell Mol Med (2003) 0.90
Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes. J Pharmacol Exp Ther (1994) 0.90
Beneficial effects of iloprost in the stunned canine myocardium. Circ Res (1988) 0.89
Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling. J Bone Miner Res (2000) 0.89
Increased tolerance of the chronically hypoxic immature heart to ischemia. Contribution of the KATP channel. Circulation (1997) 0.89
Mitochondrial K(ATP) channels: triggers or distal effectors of ischemic or pharmacological preconditioning? Circ Res (2000) 0.88
Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation (1996) 0.88
Effect of ortho-iodo sodium benzoate on hemoglobin-oxygen affinity in normal and ischemic myocardium. J Pharmacol Exp Ther (1977) 0.88
Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics? Circ Res (2000) 0.87
Determination of experimental myocardial infarct size. J Pharmacol Methods (1981) 0.87
Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil. Cardiovasc Drugs Ther (1992) 0.87
Nitric oxide activates the sarcolemmal K(ATP) channel in normoxic and chronically hypoxic hearts by a cyclic GMP-dependent mechanism. J Mol Cell Cardiol (2001) 0.87
Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol (1999) 0.87
Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol (1993) 0.86
Time course of recovery of "stunned" myocardium following variable periods of ischemia in conscious and anesthetized dogs. Am Heart J (1987) 0.86
Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovasc Res (1995) 0.86
Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs. J Cardiovasc Pharmacol (1984) 0.85
Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol (1997) 0.85
Mechanism of coronary vasodilation produced by bradykinin. Circulation (1991) 0.85
Positive inotropic actions of the calcium channel stimulator, Bay k 8644, in awake, unsedated dogs. Basic Res Cardiol (1985) 0.85
Comparative effects of cardioselective versus noncardioselective beta blockade on subendocardial blood flow and contractile function in ischemic myocardium. Am J Cardiol (1979) 0.85
Resection of solitary metastasis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol (1984) 0.85
Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol (2001) 0.84
Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation. Eur J Pharmacol (2000) 0.84
Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology (1997) 0.84
Analysis of coronary vascular beta receptors in situ. Am J Physiol (1975) 0.84
The ATP-dependent potassium channel: an endogenous cardioprotective mechanism. J Cardiovasc Pharmacol (1994) 0.84
Coronary steal-induced increase in myocardial infarct size after pharmacologic coronary vasodilation. Am J Cardiol (1980) 0.84
Na(+)/H(+) exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes. Am J Physiol Heart Circ Physiol (2000) 0.84
Effects of monophosphoryl lipid A on myocardial ischemia/reperfusion injury in dogs. J Cardiovasc Pharmacol (1993) 0.84
Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs. Anesthesiology (1987) 0.83
Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection. Anesthesiology (1998) 0.83
Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model. J Pharmacol Exp Ther (1984) 0.83
Dependence of delta1-opioid receptor-induced cardioprotection on a tyrosine kinase-dependent but not a Src-dependent pathway. J Pharmacol Exp Ther (2001) 0.83
Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol (1997) 0.83
Transmural distribution of blood flow during activation of coronary muscarinic receptors. Am J Physiol (1981) 0.83